Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
基本信息
- 批准号:8792640
- 负责人:
- 金额:$ 55.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-19 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdultAdverse effectsAgreementAlcohol or Other Drugs useAnxietyBehavior TherapyBlood PressureCardiovascular DiseasesCaringCharacteristicsChronicClinical TrialsCognitive TherapyCollaborationsCommunity MedicineConsciousConsent FormsDataData CollectionDiagnosisDropsEducational MaterialsElectronic Health RecordElectronicsFatigueFeedbackHealthHealth Care CostsHealth systemHealthcareHome Blood Pressure MonitoringHome environmentHumanHypertensionImpaired healthInstitutional Review BoardsInternetInterventionLifeLocationManualsMeasuresMedicalMedical centerMental DepressionModelingMonitorOnline SystemsOutcomeOutcome MeasureParticipantPatient EducationPatient Outcomes AssessmentsPatient Self-ReportPatientsPharmaceutical PreparationsPhasePhysicians&apos OfficesPrimary Care PhysicianPrimary Health CareProtocols documentationProviderQuality IndicatorRandomizedRandomized Controlled TrialsRecruitment ActivityReportingResearchResearch InfrastructureResearch PersonnelResourcesRiskSleepSleep disturbancesSleeplessnessSymptomsTelephoneTestingTimeTreatment outcomeUniversitiesbasebrief interventioncostexperiencehealth care service utilizationhealth related quality of lifehypnoticinnovationmortalitynew technologynondrug therapynovelpatient orientedpragmatic trialprimary care settingprimary outcomeresponsesatisfactionscreeningsecondary outcometooltreatment as usualtrial comparing
项目摘要
DESCRIPTION (provided by applicant): Insomnia is a prevalent, chronic, and inadequately-treated chronic medical condition associated with comorbid conditions such as hypertension (HTN) and a range of adverse health outcomes. Hypnotic medications are efficacious and widely available, but they have potentially serious adverse effects. Patients and providers prefer non-drug treatments such as Cognitive-Behavioral Treatment of Insomnia (CBT-I), which is safe, efficacious, and durable-but not widely available. Innovative use of electronic health records (EHR) to identify patients, and the availability of new technologies that enable cognitive-behavioral interventions to be delivered at scale, with high treatment fidelity, and at low cost, offer exciting opportunities to address these critical problems. In response to RFA-HL-14-019, we propose a low-cost, pragmatic, patient-centered, randomized controlled trial comparing two CBT-I-based interventions for insomnia with comorbid hypertension (INS+HTN) to primary care physicians' (PCP) usual care (UC). The setting will be University of Pittsburgh Medical Center (UPMC) primary care practices. Participants will be 625 adults with INS+HTN. Recruitment will be conducted using alerts in the EpicCare EHR triggered by patient characteristics (hypertension; hypnotic medications or insomnia diagnosis/problem). We will compare 3 interventions: Brief Behavioral Treatment of Insomnia (BBTI), involving electronic educational material and 4 telephone/web sessions with a live interventionist; "Sleep Healthy Using The Internet" (SHUTi), a self-guided, 8-module, Internet version of CBT-I, with no human contact; and UC. The primary outcome will be self-reported sleep at 3 months. Other outcomes include domains of symptoms, health, and patient/provider satisfaction obtained by self-report, home blood pressure monitoring (HBPM), and EHR. Specific Aims for the UH2 phase are: (1) To finalize institutional infrastructure and (2) To finalize the trial infrastructure. Specific Aims fr the UH3 phase are: (1) To compare interventions on patient-reported symptoms at 3, 6, and 12 months. The primary outcome is the PROMIS Sleep Disturbance scale at 3 months. Hypothesis: BBTI and CBT-I will be superior to UC on patient-reported outcomes. (2) To compare interventions on health indicators including self-report, HBPM, and EHR measures at 6 and 12 months. Hypothesis: BBTI and CBT-I will be superior to UC on each health outcome. (3) To compare patient and provider-level satisfaction with the 3 interventions. Hypothesis: BBTI and CBT-I will be superior to UC on patient and provider satisfaction. (4) Exploratory Aim: To compare BBTI and CBT-I on each outcome domain and intervention adherence/drop-outs. This proposal capitalizes on our expertise in traditional and internet insomnia interventions, collaboration with UPMC and primary care practices, and EHR-based recruitment; it addresses a significant health problem using a scalable model of screening and treatment; it assesses outcomes relevant to patients, providers, and health systems; it uses an innovative EHR recruitment strategy; and it integrates efficacious, low-cost, scalable, pragmatic sleep interventions into primary care settings.
描述(由申请人提供):胰岛素抵抗是一种流行的、慢性的、治疗不充分的慢性疾病,与高血压(HTN)等共病和一系列不良健康结局相关。催眠药物是有效的,广泛使用,但它们有潜在的严重不良反应。患者和提供者更喜欢非药物治疗,如认知行为治疗(CBT-I),这是安全的,有效的,持久的,但不是广泛使用。创新性地使用电子健康记录(EHR)来识别患者,以及新技术的可用性,使认知行为干预能够以高治疗保真度和低成本大规模提供,为解决这些关键问题提供了令人兴奋的机会。作为对RFA-HL-14-019的回应,我们提出了一项低成本、务实、以患者为中心的随机对照试验,将两种基于CBT-I的失眠伴高血压(INS+HTN)干预措施与初级保健医生(PCP)的常规护理(UC)进行比较。该设置将是匹兹堡大学医学中心(UPMC)的初级保健实践。参与者将是625名患有INS+HTN的成年人。将使用EpicCare EHR中由患者特征(高血压、催眠药物或失眠诊断/问题)触发的警报进行招募。我们将比较3种干预措施:简易行为治疗(BBTI),包括电子教育材料和4个电话/网络会议与现场干预;“使用互联网的健康睡眠”(SHUTi),一个自我指导,8个模块,CBT-I的互联网版本,没有人类接触;和UC。主要结果将是3个月时自我报告的睡眠。其他结果包括症状,健康和患者/提供者满意度的领域,通过自我报告,家庭血压监测(HBPM)和EHR获得。UH 2阶段的具体目标是:(1)完成体制基础设施;(2)完成试验基础设施。UH 3阶段的具体目的是:(1)比较3、6和12个月时对患者报告症状的干预。主要结局是3个月时的PROMIS睡眠障碍量表。假设:在患者报告的结局方面,BBTI和CBT-I将上级优于UC。(2)比较干预措施对健康指标的影响,包括6个月和12个月时的自我报告、HBPM和EHR测量。假设:BBTI和CBT-I在每个健康结局上都上级UC。(3)比较患者和提供者对3种干预措施的满意度。假设:BBTI和CBT-I在患者和提供者满意度方面上级UC。(4)探索性目的:比较BBTI和CBT-I在每个结局领域和干预依从性/脱落率方面的差异。该提案利用了我们在传统和互联网失眠干预方面的专业知识,与UPMC和初级保健实践的合作,以及基于EHR的招聘;它使用可扩展的筛查和治疗模型解决了一个重大的健康问题;它评估了与患者,提供者和卫生系统相关的结果;它使用了创新的EHR招聘策略;它将有效的、低成本的、可扩展的、实用的睡眠干预整合到初级保健环境中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel J. Buysse其他文献
A randomized trial of adapted versus standard versions of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction implemented via facilitation and delivered by community mental health providers: improving the “fit” of psychological treatments by adapting to context
- DOI:
10.1186/s13012-025-01440-9 - 发表时间:
2025-07-09 - 期刊:
- 影响因子:13.400
- 作者:
Allison G. Harvey;Emma R. Agnew;Rafael Esteva Hache;Julia M. Spencer;Marlen Diaz;Estephania Ovalle Patino;Anne Milner;Lu Dong;Amy M. Kilbourne;Daniel J. Buysse;Catherine A. Callaway;Laurel D. Sarfan - 通讯作者:
Laurel D. Sarfan
Correction to: Subjective and neural reactivity during savoring and rumination
- DOI:
10.3758/s13415-023-01145-w - 发表时间:
2024-02-20 - 期刊:
- 影响因子:2.700
- 作者:
Benjamin O. Brandeis;Greg J. Siegle;Peter Franzen;Adriane Soehner;Brant Hasler;Dana McMakin;Kym Young;Daniel J. Buysse - 通讯作者:
Daniel J. Buysse
Alpha-2-adrenergic agonists reduce resting energy expenditure in humans during external cooling
α-2-肾上腺素能激动剂可减少外部冷却期间人体的静息能量消耗
- DOI:
10.1080/23328940.2024.2339781 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Clifton W. Callaway;Katharyn L Flickinger;Alexandra Weissman;Francis X. Guyette;Ryann DeMaio;Andrea Jonsson;Victor Wu;Jenna L. Monteleone;Peter Prescott;Jonathan Birabaharan;Daniel J. Buysse;P. Empey;Thomas D. Nolin;Raymond E. West - 通讯作者:
Raymond E. West
総合病院精神科におけるアルコール健康障害への取り組みと、「減酒外来」について
综合医院精神科和“戒酒门诊”致力于治疗酒精相关疾病
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Ryuji Furihata;Yukiko Tateyama;Yukako Nakagami;Toshiki Akahoshi;Osamu Itani;Yoshitaka Kaneita;Daniel J. Buysse;角南隆史 - 通讯作者:
角南隆史
Sleep intervention and glycemic control in gestational diabetes mellitus: a feasibility study
妊娠期糖尿病中的睡眠干预与血糖控制:一项可行性研究
- DOI:
10.1016/j.ajogmf.2022.100836 - 发表时间:
2023-02-01 - 期刊:
- 影响因子:3.100
- 作者:
Roxanna M. Twedt;Daniel J. Buysse;Peter L. Franzen;Megan E. Hamm;Francesca L. Facco - 通讯作者:
Francesca L. Facco
Daniel J. Buysse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel J. Buysse', 18)}}的其他基金
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
基于客观睡眠持续时间的 1/2 认知行为疗法和曲唑酮对失眠表型睡眠和血压的影响:序贯队列/随机对照试验
- 批准号:
10590135 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
- 批准号:
9125875 - 财政年份:2014
- 资助金额:
$ 55.58万 - 项目类别:
Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
- 批准号:
9325558 - 财政年份:2014
- 资助金额:
$ 55.58万 - 项目类别:
Dimensional Sleep Disturbance in Relation to Positive/Negative Affect Systems
与积极/消极情感系统相关的维度睡眠障碍
- 批准号:
8765960 - 财政年份:2014
- 资助金额:
$ 55.58万 - 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
- 批准号:
8255615 - 财政年份:2008
- 资助金额:
$ 55.58万 - 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
- 批准号:
7817029 - 财政年份:2008
- 资助金额:
$ 55.58万 - 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
- 批准号:
8071232 - 财政年份:2008
- 资助金额:
$ 55.58万 - 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
- 批准号:
7626661 - 财政年份:2008
- 资助金额:
$ 55.58万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 55.58万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 55.58万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 55.58万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 55.58万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 55.58万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 55.58万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 55.58万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 55.58万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 55.58万 - 项目类别: